The doctrine of intellectual property is based on the assumption that the exclusivity to commercialize a novel product granted to an inventor creates incentives to conduct research. In some areas, however, intellectual property can constitute a barrier to development of social welfare. In the area of access to medicines in developing countries, the intellectual property-related problem can take two forms. When needed products are not being developed and thus do not exist, lack of availability occurs. Lack of accessibility, on the other hand, arises when necessary medicines do exist, but their prices are prohibitive for people from resource-poor countries. Based on a detailed analysis of the patent and trade environment in the pharmaceutical sector, the thesis examines the potential of patent pooling as a joint intellectual property management strategy to increase access to medicines within the existing international intellectual property system. Particularly, it analyzes the effects of an existing pharmaceutical pool, the Medicines Patent Pool, on accessibility of antiretroviral medicines in low and middle income countries.

The truck manufacturing field is expected to go through a disruptive change in the coming decade(s) due to a predicted implementation of autonomous (self-driving) heavy-duty vehicles. Here, companies face a challenge in that autonomous vehicles (AV) will include technologies and competences from multiple industries. This will most likely have an impact on how companies manage their intellectual property (IP) to protect their inventions if they wish to keep up with the changing market. To do this in the most optimal way, it is argued that a company’s IP-strategy needs to be incorporated into their business strategy. At the same time, studies show that companies are experiencing difficulties in extracting the full potential of their IP-management. Hence, this master thesis aims at investigating how a truck manufacturing company can adapt their IP-management policy in line with future developments within these emerging technologies and how their IP-strategy can become intertwined with their business strategy. Next to a literature review of these fields, the thesis conducts a qualitative case study of a truck manufacturer that intends to be part of this change based on 11 semi-structured interviews. From the empirical results, the company’s decision-making process regarding IP is identified, whereby this thesis suggests four points of improvement that could make their IP-management policy more effective. Further, this study presents three actions that can be taken in a company to incorporate their IP-strategy with their overall business strategy. The study ends with giving suggestions for future research and presenting six managerial implications that would come by implementing the suggestions made in this thesis.

The South African property sector is characterised by property practitioner firms that fail to comply with the Estate Agency Affairs Board (EAAB) code of conduct and firms having inefficient systems which are unable to combat hacking and cybercrime in the sector. Although property practitioner firms have systems and processes in place, there are still instances of unethical behaviour. Failure to prevent client personal information from being leaked is still a major problem in the sector, this issue can be addressed by demonstrating due diligence with respect to safeguarding sensitive information. The accuracy of information is also a problem in the sector and requires firms to resort to analysing collected data before capturing it, in order to maintain accuracy. The sector encounter illegal access to systems including breaking the password protected websites and password protection on a computer system. The objectives for this study were to investigate the extent to which firms enforce Information Ethics (IE), explore the systems and processes put in place by firms to enforce IE and to explore the challenges experienced by the firms in the Gauteng province when enforcing IE. The study was qualitative in nature and indepth interviews were conducted to gather information from five managers and five employees within the firm situated in Gauteng province. The study found that these property practitioner firms enforce IE to a certain extent. These firms use (22) systems and processes to enforce IE and experienced (5) challenges during the enforcement of IE. The study concludes that these property practitioner firms enforce IE using different systems and processes and experience challenges during enforcement. The list of IE enforcement systems and processes and challenges identified in this study will assist policy makers in compiling IE policies. The findings will also assist firms in IE enforcement and reduction of IE enforcement challenges. / Business Management / M. Com. (Business Management)

90年代歐美國家，對於人口增加、土地面積驟減、過量電子產品等所帶來的環境問題日益重視。歐洲最早發起「延伸生產者責任制」，透過制訂法律與政策提升資源再生利用的效率。並且陸續頒佈WEEE廢電機電子指令、RoHS有害物質限用指令、REACH化學品限制、ELV廢車輛指令等，透過污染控制、回收利用、減廢、污染預防、清潔生產等步驟，朝零污染方向進行，顯示資源再生的重要性。 資源再生產業在台灣為新興產業，規模以中小企業形式居多，雖然經營回收事業容易，但要經營技術層次較高的再生事業則需獲得政府許可證使得成為再生機構。近年來資源再生廠商利用廢棄物資源再生的技術，提煉出黃金、白銀、鉑等貴金屬，隨著全球原物料價格高漲，其所生產的二次原材料行情提升整體產值，預估到2010年總產值為580億台幣。 智慧資本目前普遍被認為是企業能形成競爭優勢的無形資產總和，即企業能用來作為開創財富的知識、資訊、智慧財產、經驗等。找出適合企業的智慧資本項目，讓企業投入在重要項目而獲取價值成為企業的重要課題。本文主要研究資源再生產業智慧資本經營方式，探討一般經營策略與智慧財產管理，對智慧資本運用與累積的影響。總結文獻探討與個案訪談分析的結果，根據研究問題，主要研究發現如下： 一、 資源再生產業為一特許經營行業，其經營需獲得政府所頒發之許可同意，同時易受上游產業廢棄物種類以及全球環保再生法規的影響。 二、 智慧財產需要透過企業策略與功能性活動執行才能提升成為智慧資本。 三、 策略目標不同將會影響智慧資本各構面投入的重要性判斷。 四、 智慧資本經營必須搭配策略與智慧財產管理制度才能達到創造、保護、管理、運用之功效。 五、 資源再生產業的智慧資本經營必須考量各國差異產生在地化的經營型態。 / Since the 1990s, the United States and the European Union (‘’EU’’) have become aware of the crucial environmental problems stemming from overpopulation, reducing residential areas, and growing quantities of end-of-life electronics. To protect the environment and diminish the impacts of household consumption and production, the EU took initiatives to devise environment policies and came up with the idea of Extended Producer Responsibility(‘’EPR’’), a strategy designed to promote the integration of environmental costs associated with products throughout their life cycles into the market price of the products. This concept is inspiring in the waste management, and urging industries to think over recycling process and use recyclable materials to produce products. Moreover, there are four important directives and policies in effect in the Europe, such as Waste Electrical and Electronic Equipment Directive (‘’WEEE’’), Restriction of Hazardous Substance Directive (‘’RoHS’’), End-of Life Vehicles Directive (‘’ELV’’), Registration, and Evaluation, Authorization and Restriction of Chemicals (‘’REACH’’). Those legislations and standards are intended to encourage companies to voluntarily adopt environmental management systems or procedures to minimize waste and emissions and to meet the goal of zero pollution. Recycling industry in Taiwan is an emerging industry and many of them are small and medium enterprises. To operate recycling business, companies have to acquire the certificate of waste management from the Environmental Protection Administration Executive Yuan. Recently, some recycling companies make it technologically possible for kinds of wastes or unwanted products to be recycled. They have developed technologies to recover from waste to precious metals like palladium, platinum, gold, or silver. Those precious metals are valuable secondary raw materials and will contribute good revenues to recycling market. Therefore, the value of recycling market in Taiwan is estimated to rise to NT$5.8 billion by 2010. Intellectual capital is widely considered as a firm’s intangible assets and is often a major determinant of the companies’ profits. It plays a crucial role in business management and needs to be analyzed in a systematic way to find out the appropriate components. This research focuses on how the companies in recycling industry manage their intellectual capitals, and how the generic strategies and the intellectual property management influence the way of creating and accumulating the intellectual capitals. The important findings of this research are as follows (extraction): 1. Recycling industry is a kind of franchising business and needs to acquire the government’s agreement to operate. The development of this industry is highly influenced by the kinds of wastes of the upstream industries and the global environment legislation. 2. Intellectual assets will be converted into valuable intellectual capital by the implementation of business strategy and functional activities. 3. Different goals of strategy bring about different priorities for the resources input of intellectual capitals. 4. To achieve the goal of value creation, protection, management, and execution, the intellectual capital management needs to combine with strategy management and the intellectual property management. 5. The intellectual capital management in recycling industry must include the consideration of different local business environments of different countries.

二十一世紀是知識經濟的時代，傳統製造業所看重的有形資本已不足以維持企業優勢，無形的智慧資本在新型態的企業競爭中所扮演的角色日顯重要。各行各業都有無形資產，種類性質因產業而異，傳統製造業重視營業秘密、商譽，高科技產業的專利則是公司競爭力的核心，而屬於知識高度密集產業的生技產業更需要重視智慧資本的管理。生技產業的結構複雜，價值鏈長、分工專業、產品開發期漫長，在產品成功上市之前的開發時期中，公司資產多屬於無形的智慧資本，無法從傳統的財務報表觀察其真正的企業價值。相較於其他產業，生技公司更必須訴求於正確的無形資產管理方式，方能成功兌現其智慧資本。 本研究先藉由文獻回顧統整台灣生技產業的相關現況、過去相關智慧資本管理研究以及研發管理等議題，歸納出一般性共識與管理原則。接著依循這些重點，訪談三家台灣生技公司的經理人，包括台灣微脂體、中裕新藥與因華生技，深入了解台灣產業經營實務與現況，探討其智慧資本中的人力、組織與關係資本在個案公司內的蓄積方式，從研發管理模式、組織制度設計與智財管理等面向進行綜合比較。 本研究認為研發能量與知識管理在組織制度中的蓄積，是台灣業界經營管理上常見的盲點，台灣生技新藥業者多重視新技術的研發，普遍對智慧資本其他面向的重視程度不高，但對生技產業而言，扣除資金與技術後，公司的長期競爭力往往都是在組織發展的過程中累積而來的，忽視知識管理與組織制度的養成，對於企業長久發展有關鍵性的負面影響。研究中的個案最終都必須往累積組織資本的方向邁進，若不針對組織資本的蓄積設計恰當的管理方法，為研發人才設計合適的制度與生涯發展管道，將研發團隊的知識能量內化為企業自有資產，只期望以短期的數據績效取得資金支持，忽視智慧資本的管理與培養，並非生技產業長久經營之道。建議生技公司除了聘僱專業經理人處理資金與股東的關係外，也要重視研發長與策略長在組織中的地位，大膽給予權利，調整組織的運作模式，設計出能累積公司能量的專案管理流程，才是生技公司創造競爭力之本。 / In the era of knowledge-based economy, the tangible assets highly-valued by traditional manufacturing industry is no more enough solely to maintain industrial competency. Intangible intellectual assets become more and more important in modern commercial competitions. The intangible assets exist and vary according to different industries. Traditional manufacturing industry looks highly upon trade secrets and brand reputation while patent is the core competency to high-tech companies. Biotech industry belongs to a high knowledge-intensive business and should emphasize more on the management of intellectual assets. Biotech industry is characterized of a complicated system, a long value chain, specialized divisions of labor, and a prolonged timeline of product development. The company assets before the successful commercialization of a product are usually intangible intellectual property and a biotech company during this period cannot be accurately evaluated from traditional financial reports. Hence, compared to other business, biotech companies should resort more actively to appropriate intangible intellectual asset management to achieve a successful redemption of its intellectual assets. This thesis will firstly through the literature study depict the current condition of Taiwan biotech industry and important issues on intellectual asset management and R&D management, inducing several principles of management. Further, the study proceeds with the principles induced to examine three new ventures in Taiwan, Taiwan Liposome Company (TLO), TaiMed Biologics, and InnoPharmax. The discussion will elaborate the practice of intellectual asset management of biotech industry in Taiwan, analyzing and comparing the accumulation of human capital, organizational capital, and relationship capital in the three cases. The study proposes that Taiwan biotech companies usually neglect the accumulation and management of R&D capacity and knowledge in the enterprise organization system. The companies in question invest their resources mostly on the development of new technology and less on other intellectual assets. However, in the long run, the competency of a biotech company accumulates while the organization develops, other than the financial capital and technology. The depreciation of knowledge management and organization system will cause fatal influences on the company. The cases in the thesis must eventually develop their own organizational capital. Biotech companies need to devise appropriate management for organizational capital and preferable career paths for researchers and engineers, to internalize the knowledge capacity of the research team into the company assets. It is not beneficial to a biotech company in the long run to expect financial supports with short-termed achievements, instead of the management and cultivation of intellectual assets. It is advised that other than hiring professional manager for investor relations, the biotech company should pay more attention to the function of CRO and CSO in the organization and sufficiently authorize them into full play. It should also focus on the operation of the organization, adjusting and devising program management to accumulate knowledge capacity, to firmly establish the core competency in a biotech company.

有鑑於我國長期以來皆為技術引入國，為強調自主創新，產學合作受到了相當程度的重視，而生技製藥產業的價值鏈長、高風險、高研發成本、高知識內涵等特性，使得產學合作成為生技製藥產業中相當重要的機制。又由於上述的產業特性，使得生技製藥公司在產品上市前，所有的研發投入，皆以「無形資產」的形式，儲存在階段性的開發成果之中，因此，智慧財產的保護與管理，對生技製藥公司而言，確實有很高的重要性，智慧財產若經過妥善的經營與管理，能有效成為企業的競爭優勢來源。 本研究即以生技製藥產業之產學合作為前提，針對智財管理與企業策略因子，以產業方的觀點，探討「產學合作－智財管理－企業營運模式」三者之間的關連性，並從智財管理的四大內涵－「創造、保護、管理、運用」作為分析之構面，釐清重要議題與關鍵因素，以作為日後雙方架構合作與管理模式之依據，達到知己知彼，互信合作，創造雙贏的綜效。 本研究以個案訪談方式，訪談台灣微脂體、台灣東洋、世基生醫三間國內生技製藥公司，並根據訪談結果之分析與彙總比較，得到研究發現並提出建議如下： 1. 生技智財策略與其營運模式有關，受到獲利方式影響而採取不同的智財策略。 2. 生技產學合作成果，「權利歸屬」之模式多元化，與該成果距離商品化之成功率有關；此外，「先專利、後發表」的慣例已普遍採用，無保密與公開之衝突。 3. 智財專責部門的設立與人數配置，應隨企業的成長而增置，人才網羅應以生技背景之跨領域專業人才為主，且需經過商管課程之訓練，方能對產業發展與競爭脈動有所掌握。 4. 產學合作成果運用，與企業核心能力與互補性資產掌控度有關，國內廠商而言，「對外授權」仍然必要；運用訴訟的方式與否，與「智財策略」有關聯，並受成本因素之影響。 5. 產業方應主動積極參與產學合作，由於學界缺乏商品化之經驗，技轉辦公室現階段亦無法充份發揮功能，因此，由產業方積極參與產學合作，能以產業方敏銳的商業嗅覺協助學界補捉具有潛力的研究，發揮引導之功能，使前瞻研究能進入應用階段，而實際造福人群，同時帶動產業的活絡發展。 / Regarding that Taiwan is always in the position of “technology transfer licensee”, to emphasize the goal of innovation, academic-industrial collaboration has becoming an important issue. Especially with regards to the features of bio-pharmaceutical value chain, such as compartmentalization, high risk, high return, highly knowledge-based, the investment input is thus transformed into the form of “intangible assets”before the product actually launched. Therefore, the protection and management of intellectual property is critical to bio-pharmaceutical companies. If IP is properly managed and utilized, it could become a source of competitive advantage. This thesis is based on the study of bio-pharmaceutical academic-industrial collaborations, from an industrial perspective, focusing on IP management and strategy. Four components of IP management－development, protection, management, and exploitation, is set as major constructs of this thesis. The primary goal of this study is to find important issues and key factors toward a successful collaboration. This thesis studied three bio-pharmaceutical companies, Taiwan Liposome Company, TTY Biopharm, and Pharmigene. According to results of interviews and analytical comparison, this thesis concludes some findings and suggestions as follow: 1. The IP strategy of a bio-pharmaceutical company is related to its business model. Different profitable models should apply different IP strategies. 2. The way which academia and industry allocate the IP right and interest is diversed, according to the risk and commercialization successful rate of the collaboration. Also, “patent goes first, publication goes after”is a common route. Therefore there is no collision between secrecy and openness. 3. The establishment and expansion of in-house IP department should go in accordance with the growing of company. It is necessary for an accountable one to be bio-tech educated and further received MBA training, in order to be competent to business competition and strategic planning. 4. The exploitation of collaboration is in relation to company’s core competence and complementary assets. For Taiwan bio-pharm companies, the“licensing out”model is necessary. With regards to litigation, the attitude toward litigation is related to its IP strategy and cost of litigation. 5. The industrial part in such collaboration should take an active attitude, because the academic part lacks commercialization experience. It would be helpful for industry to guide and help capturing valuable study in academia, therefore makes radical innovation an usful one.

中文摘要 競爭策略的核心問題是企業在產業中的相對位置。競爭位置會決定企業獲利能力高出或低於産業平均水準。產業的獲利能力並非取決於產品功能或技術層次的高低，而是由產業結構決定。產品設計即使很時尚或是高科技的東西如果處於產業結構中不對的位置上，企業的獲利依然不會好。例如台灣的筆記型電腦代工產業的一直處於全球領先位置但是產業獲利卻是低毛利的狀況。 當產業有重量級競爭者進入時，新的技術可能破壞原本的產業結構，原來的產業競爭者可能受到程度不等的影響。影響的結果取決於企業應變策略及其在產業中的相對位置，應變速度慢或是選擇錯誤的策略皆可能導致公司步上衰退，而與重量級同質性高的廠商受到的衝擊往往最大，資源互補的廠商卻可能從中獲利。 此外，新的技術也可能為產業帶來新應用與新市場，使產業擴大，企業如能把握時機，妥善選擇競爭策略，為客戶創造價值，也能在產業中獲得更大的利潤。 本研究方法採用「個案研究法」來進行，探討個案企業憑藉哪些創新與競爭策略，使其能夠在重量級廠商加入產業對原來產業產生重大影響的環境中突圍，以及如何面對下一波的挑戰。得到的發現如下: (一)開發中國家的企業要成為國際企業，宜採取漸進式方式，經過多年的耕耘，逐漸成為國際知名企業。(二)智慧型手機開放性架構有利於手機生態系統的競爭，傳統電信營運商將可能淪為數位匯流時代之配角。(三)技術創新的本身並不重要，只有在技術創新影響到產業結構及企業競爭優勢的情況下，才突顯出它的重要性。(四)技術創新可能會影響產業結構，導致市場轉移，企業內現有競爭者必須快速因應。(五) 企業以大量客製化的服務方式來滿足客戶的營運模式，似乎較難進行破壞性創新。(六)企業的能力與稟賦，皆會影響公司的獲利，且會受到技術及市場知識所影響，領導企業具有提供低成本和差異化的能力與稟賦。非領導企業最好在低成本和差異化兩策略上擇一為之..等.